February 18, 2010
Additional quantities of erythromycin ointment, used for prophylaxis of ophthalmia neonatorum, have become available from two companies. Fera Pharmaceuticals is releasing ointment in 50-x-1 gram packaging, and Bausch & Lomb continues to release the medication in the same configuration.

For additional details and contact information about erythromycin ointment, go to the drug shortages page of the US Food and Drug Administration (FDA) Web site.

Previous updates and guidance on erythromycin ointment shortages can be found on the Centers for Disease Control and Prevention (CDC) Web site.